Invest in

Fighting Fat

2.7%
1.0%
1.2%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
2.7%
1.0%
1.2%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
54.6% Diabetes Care 0.1%
17.6% Merck & Company Inc. (new) MRK 27.6%
16.2% Novo Nordisk A/S NVO 15.2%
14.1% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 16.6%
3.2% Astrazeneca Plc ADR AZN 11.0%
2.1% Alkermes plc ALKS 23.2%
1.3% Integer Holdings Corporation ITGR --
37.8% Weight Management 26.1%
15.5% NutriSystem Inc NTRI 14.0%
8.5% MEDIFAST INC MED 43.3%
4.4% Nu Skin Enterprises Inc. (A) NUS 62.0%
3.6% Weight Watchers International Inc WTW 70.4%
2.3% USANA Health Sciences Inc. USNA 3.7%
1.8% Vitamin Shoppe Inc VSI 17.0%
1.7% GNC Holdings Inc. Class A GNC 50.8%
7.6% Weight Loss Drugs 30.9%
7.6% Arena Pharmaceuticals Inc. ARNA 30.9%

Quotes delayed 15 mins. Currently Sep 24, 2016 8:13:52 PM. Fields are marked with -- when data is unavailable.